VIM and colorectal cancer: Moreover, VIM-AS1 was regarded as an independent diagnostic biomarker in tumors and its expression levels were associated with cancer metastasis and poor patient prognosis, including bladder cancer, colorectal cancer, and glioma 16, 17.